No Result

View All Result

No products in the cart.

Home StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

byTeddy Guo

April 28, 2023

in StudyGraphics

Reading Time: 1 min read

Neuropsychological and biomechanical measures dominate assessment of limb pain in athletes

RelatedReports

StudyGraphics

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment

November 10, 2023

Stereotactic radiosurgery promising for patients with multiple brain metastases

Oncology

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

October 9, 2023

Key predictors of recurrence and survival for Merkel Cell Carcinoma elucidated

Chronic Disease

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

September 21, 2023

Increased frailty associated with childhood cancer survivorship

Oncology

Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma

September 18, 2023

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

Neuropsychological and biomechanical measures dominate assessment of limb pain in athletes

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

RelatedReports

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

RELATED REPORTS

Neuropsychological and biomechanical measures dominate assessment of limb pain in athletes

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?